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Cavernous hemangiomas are the most frequent tumors in the orbital 
region. Solitary fibrous tumors are uncommon neoplasms found in dif-
ferent locations, including the orbit. We present a 50 year old man with 
coincidence of unilateral orbital cavernous hemangioma and solitary 
fibrous tumor. Computed tomography was performed which showed two 
intraconal solid masses in the right orbit positioned relatively near each 
other antro-postriorly. Tumors were excised using lateral orbitotomy 
method and sent for histopathologic examination. Our case shows the 
coincidence of a solitary fibrous tumor adjacent to cavernous heman-
gioma so this combination is possible and should be considered.
Case Report
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Introduction
Solitary fibrous tumors (SFTs) have a mesenchymal 
origin (1) and are relatively rare neoplasms found 
in visceral tissue particularly in pleura (2- 4), but 
rarely develop in other locations including 
peritoneum, mediastinum, liver, pericardium, 
retroperitoneum and other anatomical structures (5, 6). 
Very rarely, SFTs develop in the eye orbit mostly 
originating in the fourth decade of life (1). These 
tumors are extremely rare among children, but 
they have been reported in some cases in the age 
range of 5 months to 16 years (5, 7). 
The clinical observations of patients with SFTs 
consist of swelling, asymmetry, slowly progres-
sive proptosis over an average of two years, loss of 
eyeball mobility and patients might complain from 
pain, diplopia and visual loss as well (5, 8). Diagno-
sis of SFTs is made by immunochemical analysis, 
therefore positive CD 34 is the main clinical test to 
validate the primary observations (1). Although the 
surgical excision of the whole tumor is considered 
as a gold standard, it can be difficult due to friabil-
ity and high vascularity (9). In addition using radio-
therapy can be helpful in reducing the tumor size 
before and after the surgery (9). 
Le et al. reviewed the key features of orbital SFT 
(OSFT) in 84 involved cases; the incidence of OSFT 
according to sex was estimated at 54 % and 45.7 % 
among males and females, respectively. Although 
the painless proptosis is considered as the most 
prevalent clinical presentation among these patients, 
ptosis might be rarely induced (3.5 %) (10). The most 
common location for the tumor is the supero-medial 
orbital wall (10). It has been reported that 74 % of 
OSFTs are indolent and are not aggressive (10). 
We present a 50 year old man with coincidence 
of unilateral orbital cavernous hemangioma and 
solitary fibrous tumor. 
Case Report
A 50-years-old Iraqi man presented with priorbit-
al edema and proptosis and gradually  increasing 
mild pain in the right eye (since many years ago).
Uncorrected visual acuity was 20/200 in the right 
eye and 20/20 in the left eye, but corrected visual 
acuity with cyclorefraction (+2.50 - 0.50 × 45°) 
was 20/25 in the right eye.
On external examination the right eye had 4 mm 
proptosis, but ocular motility was normal and no 
afferent pupillary defect was detected. Slit lamp ex-
amination was normal in both eyes, the right eye’s 
intraocular pressure was 17 mmHg and the left eye’s 
intraocular pressure was 13 mmHg. Fundoscopic 
examination was normal in both eyes and optic disc 
appearance was pink with sharp margins. 
Computed tomography (CT) was performed. On 
CT two axial and intraconal separate solid mass-
es in the right orbit positioned relatively near 
each other antro-postriorly were observed. 
The lateral orbitotomy method was planned in 
order to obtain the best access to remove the tumor 
and the excised tumor was sent for the his-
topathologic examination. The lateral orbital 
wall was dissected from the bone with blunt 
periosteal elevation. The lateral periorbita 
was dissected posteriorly to the posterior 
one fourth of the orbit, exposing the lateral 
orbital wall. After excising the anterolateral 
orbital wall, removal of the posterior wall 
was completed. A periorbital incision was 
made, avoiding the lateral rectus muscle. Handheld 
retraction was used to retract the globe anteriorly 
and to retract the orbital soft tissues. When the 
tumor was identified, it was dissected using 
blunt techniques with cotton-tipped applicators 
and microdissection instruments. A cryoprobe 
with special elongated orbital tip was placed on 
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the lesion to provide traction. The cryoprobe was 
sequentially replaced as the tumor was rolled out. 
The process continued until the tumor was freed 
up entirely and could be removed. After achieving 
complete hemostasis, closure was performed. 
Macroscopic examination of the histopathologic 
observations revealed an ovoid grayish soft tissue 
(2 × 1.5 × 1cm) with hemorrhagic background 
accompanied by two irregular grayish-brown soft 
tissues (1.5 × 1.5 cm).
In addition, microscopic evaluation of histopatho-
logic observations showed a benign neoplastic 
lesion characterized by patternless architecture 
of spindle cells, branching hemangiopericytoma 
like vessels, and keloidal type collagen deposition 
(Figure 1).
Also a benign neoplastic lesion composed of 
spindle cells having elongated nuclei with 
focal mild nuclear atypia was observed. On 
immunohistochemistrical study spindle cells 
showed strongly positive CD 34 and CD 99 
(Figure 2). Therefore the diagnosis was compatible 
with cavernous hemangioma accompanied with 
solitary fibrous tumor.
Discussion
Cavernous hemangiomas are the most frequent-
ly found primary tumors in the orbital region. 
They normally appear in adults (11, 12). Solitary 
fibrous tumors are uncommon neoplasms found 
in visceral tissue particularly in pleura (2-4). These 
tumors are also rarely found in the orbit (2-4). 
Although orbital cavernous hemangiomas are 
typically unilateral, some reports have reported 
bilateral cases (13-15). Ali et al., (1) presented a 22 
year old man with proptotic eyeball and down-
ward displacement due to OSFT which caused 
ocular movement restriction. Tumor was excit-
ed completely along with the overlying capsule. 
There was no evidence of tumor recurrence after 
6 months of follow up examinations. Le et al. 
have reported four patients with unilateral OS-
FTs inducing painless proptosis, facial deformity, 
globe displacement and also diplopia (10). The tumor 
Figure 1: Evaluation of histopathologic observations showed a benignneoplastic lesion characterized by patternless 
architecture of spindlecells, branching hemangiopericytoma like vessels, and keloidal type collagen deposition.
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 Figure 2: In immunohistochimestrical study spindle cells show strongly  positive CD 34 and CD 99.
was removed completely with medial and later-
al orbitotomy (10). The pathological diagnosis of 
a solitary fibrous tumor, in comparison to other 
mesenchymal tumors such as hemangiopricytoma, 
can be difficult (16). Bcl-2 and CD 99 immunohis-
tochemistriy were used to distinguish a solitary 
fibrous tumor from a hemangiopriocytoma be-
cause a solitary fibrous tumor is positive for Bcl-
2 and CD 99 but these markers are negative for 
hemangiopricytoma (16). To our knowledge only 
one case of splenic hemangiopricytoma adjacent 
to cavernous hemangioma of colon have been re-
ported in the English literature (17), but no case of 
solitary fibrous tumor and cavernous hemangioma 
has been previously reported.
Conclusion
Our case shows the coincidence of a solitary 
fibrous tumor adjacent to cavernous hemangio-
ma so this combination is possible and should be 
considered.
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